• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

3v.org

Venture Capital Matters

  • Pitch a Startup
    • Make a Contribution
  • Market Reports
  • Technologies
    • Technology Events
  • Domain Names for Startups
  • About
  • Contact

ETECTRX, INC. ANNOUNCES ISSUANCE OF ADDITIONAL U.S. PATENTS FOR INGESTIBLE MEDICATION ADHERENCE SYSTEM

June 10, 2019 By admin Leave a Comment

etectRx™ Inc., an early-stage digital health company, today announced that the United States Patent and Trademark Office has issued U.S. Patent 10,292,642 for an “Electronic Medication Compliance Monitoring System and Associated Methods.” The patent covers an ingestible electronic system and methods for recording and tracking a patient’s adherence to a medication. etectRx has exclusive worldwide rights to the patented technology. The company has also received a notice of allowance and issue notification for U.S. Patent 10,321,849 for a “System for Ingestion Event Monitoring and Method for Detecting Ingestion Events with High Accuracy.”

These patents are part of a growing intellectual property portfolio of pending and granted patents that cover etectRx’s unique and proprietary technology in the U.S. and major international markets. They will also enable the commercialization of new products, services, and platform technologies to serve a broad range of markets.

etectRx is developing an ingestible event marker (the ID-Cap™ System), which gives clinicians and researchers the ability to accurately track and manage patients’ medication adherence on a per-dose basis. This proprietary technology has a unique mode of action. The ID-Cap System uses a novel ingestible sensor (the ID-Tag), which is delivered within a standard, hard gelatin capsule shell (the ID-Capsule). The ID-Tag is powered by stomach fluid and emits very low-power digital messages from within the patient each time an ID-Capsule is ingested. The messages are transmitted to a wearable reader (the ID-Cap Reader) and can be forwarded to the patient’s smartphone through a mobile application (the ID-Cap App).

“We are confident that these additional patents will broadly protect etectRx’s technology and provide our products with long-term market value,” said Harry J. Travis, president & CEO of etectRx. “These patents are important assets in etectRx’s intellectual property portfolio covering the ID-Cap System and our unique methods for monitoring patient adherence to medications.”

About etectRx, Inc.
etectRx is a privately held digital health company seeking to advance patient medication adherence and improve medication ingestion tracking technology. etectRx’s flagship product, the ID-Cap System, is an ingestible event marker that is comprised of a gelatin capsule containing a wireless ingestible sensor, which transmits signals to a wearable reader and then to a smartphone-based app and secure cloud-based server to enable reliable tracking of ingestion events.

etectRx submitted a premarket notification (510(k)) application with the U.S. Food and Drug Administration (FDA) for its ID-Cap System as an ingestible event marker in late 2018 and anticipates FDA clearance for marketing in 2019. The ID-Cap System is currently only available for investigational use in IRB-approved clinical studies.

To learn more about etectRx, visit https://etectrx.com.

Filed Under: PR

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Market Analysis

The future of global healthcare in 2022
AIML.ag: AIML is the future of agriculture
ResilientSupplies.com (Resilient Supplies): Supply chain resilience is the key to withstand pandemic-related disruptions
RealPage® Releases 2022 Market-Rate Apartment Affordability Report
Additive Manufacturing at industrial scale
The highest share of enterprises selling online in 2020 in EU was in Denmark, Ireland and Sweden
Low-carbon fuels will be essential for decarbonization

Market Research Media

ImpactfulTrends.com (Impactful Trends): Trends to Watch in 2022
LuxurySucks.com (Luxury Sucks) vs BornIntoLuxury.com (Born Into Luxury): How do luxury brands adapt in the rapidly changing world?
Revenues in the entertainment and media industry are on the rise globally
52% of retail activities could be automated
SetupMarket.com: How to set up a direct-to-consumer (DTC) channel
MultimodalRetail.com (Multimodal Retail): Should retailers split e-commerce operations from stores?
TechnologyConference.com Presents Upcoming Events

Secondary Sidebar

Technologies

Samsung Unveils ISOCELL Image Sensor with Industry’s Smallest 0.56μm Pixel
Europe’s technology sector is set to bring in more than $100 billion of annual investment
Cloudflare announces Workers for Platforms
New Zealand’s leading port, Ports of Auckland, welcome the world’s first full sized, electric tugboat
New Greentech Start-Up, Refhuel, to Develop Reversible Fuel Cell Technology

Tech Events

Intel Event at Mobile World Congress, June 21, 2021
DesignCon, the premier event in high-speed communications and system design, August 16-18 2021, San Jose McEnery Convention Center
JavaScript Congress 2021, November 23-25, 2021
WeAreDevelopers World Congress, 14-15 June 2022, Berlin
PIE Astronomical Telescopes + Instrumentation Symposium, 17-22 July 2022, Montréal

Footer

Recent Posts

  • Breakthrough VR Basketball App Gym Class Closes $8 Million in Seed Round Led by Andreessen Horowitz
  • Techstars and Audi Launch Pre-Accelerator Program to Promote Innovation in Mobility
  • Latchel Closes $16.7 Million to Enhance Resident Services and Maintenance Workflow
  • Seedtag raises over €250M from Advent International
  • Arable Raises $40 Million to Accelerate Sustainable Agriculture
  • European Quantum Computing Leader IQM Raises €128m Led by World Fund to Help Combat the Climate Crisis
  • Whatnot raises $260M Series D co-led by DST Global and CapitalG to expand its live, social commerce marketplace
  • ZeroAvia Secures Additional $30 Million in Funding from IAG, Barclays, NEOM & AENU
  • Medusa Raises $8m to Build the Leading E-Commerce Platform for Developers
  • Blue Ocean Barns Completes $20 Million Series A Financing, Accelerating Solution to Agricultural Methane Emissions

Dossier

What were the top technology, media, and telecommunications (TMT) companies for total shareholder return (TSR)?
Elkem commissions two climate-friendly ships for North Sea operation from NCL and MPC Container Ships
Future of the traditional classroom-based MBA vs online
Thoma Bravo buys control of Applitools in $300m deal
The Economist on Twitter: “In a 114-page review of Britain’s foreign, security, defence and aid policy, the government is finally fleshing out what “Global Britain” means

Press Media Release

Frontline MNA Nurses and Healthcare Professionals Voice Concerns Regarding Hospital Preparedness and Policies in Response to COVID-19 Second Surge
Across International’s Ultra Low-Freezers (ULT) Can Distribute the COVID-19 Vaccine on Global Scale
AT&T and The Texas A&M University System’s RELLIS Campus to Launch 5G Technology to Promote 5G Innovation, Exploration, Education and Training
The Salvation Army and Convoy of Hope Partner Together to Meet the Needs of Ukrainian Refugees
What happens to the Internet traffic in countries where many observe Ramadan?

App Coding

ScaleOut Software Announces Production Release of Redis®* Integration
Digital twins transform the efficiency of current business processes
Configit Introduces Breakthrough System-Level Configuration Solution
Browser innovation has stalled
Dynamic forms for your React app

API Coding

RapidAPI opens European headquarters at the new location in Berlin
Are you looking for an API for OCR (Optical Character Recognition)?
WSO2 Completes $93 Million Series E Growth Funding Round with the Investment from Info Edge
What is a REST API?
DarkOwl Announces Release of Ransomware API

Copyright © 2022 3v.org

Technologies, Market Analysis & Market Research

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT